Clinical Trials Directory

Trials / Completed

CompletedNCT03294356

CSD170304: Study to Assess Nicotine Uptake in Smokers From Electronic and Combustible Cigarettes

CSD170304: An Unblinded, Parallel, Randomized Study to Assess Nicotine Uptake in Smokers From Electronic and Combustible Cigarettes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
210 (actual)
Sponsor
RAI Services Company · Industry
Sex
All
Age
21 Years – 60 Years
Healthy volunteers
Accepted

Summary

To determine the rate and amount of nicotine uptake with 10-minute ad libitum use of five different marketed electronic cigarettes, or one combustible cigarette (CC). Furthermore, to measure overall product liking by subjects to assess potential willingness to seek out the Electronic Cigarette (EC) again in the future.

Detailed description

This will be a single-center, randomized, open-label, parallel study during which up to 210 healthy adult subjects, consisting of 35 subjects per product group, will be enrolled. Subjects will be evaluated for plasma nicotine uptake, as well as overall product liking. The study will involve the use of five different marketed ECs or one CC in tobacco consumers who are exclusive smokers (i.e., naïve EC users) or dual users of cigarettes and ECs (i.e., intermittent EC users).

Conditions

Interventions

TypeNameDescription
OTHERFT210771An electronic cigarette
OTHERFT210751An electronic cigarette
OTHER6T30134157764An electronic cigarette
OTHERG41A7C071An electronic cigarette
OTHERM011161212An electronic cigarette
OTHERFT21002A combustible cigarette

Timeline

Start date
2017-09-13
Primary completion
2017-11-02
Completion
2017-11-02
First posted
2017-09-27
Last updated
2017-11-14

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03294356. Inclusion in this directory is not an endorsement.